News
Latest updates on our clinical development programs and company milestones.
Celfex AB opens CRO partner discussions for Phase 2
Celfex AB opens CRO partner discussions and plans for its Phase 2 clinical study, with partner selection and announcement planned for BIO 2026.
Read more →Celfex AB established as SPV, enters sub-licensing agreement with OrchestratePharma GmbH
Through Celfex AB, Swiss-based OrchestratePharma enters into a co-development partnership with Cellix Bio and other strategic CRO partners.
Read more →